免疫检查点抑制剂联合抗血管生成药物治疗pMMR/MSS型结直肠癌的机制与临床研究进展

袁汇, 李红, 宋扬

PDF(1756 KB)
RSS服务E-mail Alert
军事医学
军事医学 ›› 2026, Vol. 50 ›› Issue (4) : 297-304. DOI: 10.7644/j.issn.1674-9960.2025-00189
综述

免疫检查点抑制剂联合抗血管生成药物治疗pMMR/MSS型结直肠癌的机制与临床研究进展

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

Research progress in mechanisms and clinical applications of immune checkpoint inhibitors combined with anti-angiogenic drugs in the treatment of pMMR/MSS colorectal cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2026, 50(4): 297-304 https://doi.org/10.7644/j.issn.1674-9960.2025-00189
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 50(4): 297-304 https://doi.org/10.7644/j.issn.1674-9960.2025-00189

参考文献

原文顺序 | 文献年度倒序 | 文中引用次数倒序

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}
PDF(1756 KB)

Accesses

Citation

Detail
段落导航
相关文章

/

〈 〉